000			01569 a2200433 4500
005			20250514190201.0
264		0	_c20050111
008			200501s 0 0 eng d
022			_a1535-7163
040			_aNLM _beng _cNLM
100	1		_aMobley, James A
245	0	0	_aThe novel estrogen 17alpha-20Z-21-[(4-amino)phenyl]-19-norpregna-1,3,5(10),20-tetraene-3,17beta-diol induces apoptosis in prostate cancer cell lines at nanomolar concentrations in vitro. _h[electronic resource]
260			_bMolecular cancer therapeutics _cMay 2004
300			_a587-95 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aBlotting, Western
650	0	4	_aBromodeoxyuridine
650	0	4	_aCaspase 3
650	0	4	_aCaspases _xmetabolism
650	0	4	_aCell Cycle _xdrug effects
650	0	4	_aCell Line, Tumor
650	0	4	_aDrug Screening Assays, Antitumor
650	0	4	_aEstradiol _xanalogs & derivatives
650	0	4	_aEstrogen Receptor alpha _xmetabolism
650	0	4	_aEstrogen Receptor beta _xmetabolism
650	0	4	_aFlow Cytometry
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aModels, Molecular
650	0	4	_aProstatic Neoplasms _xpathology
650	0	4	_aProtein Binding
700	1		_aL'Esperance, James O
700	1		_aWu, Mengchu
700	1		_aFriel, Carolyn J
700	1		_aHanson, Robert H
700	1		_aHo, Shuk-Mei
773	0		_tMolecular cancer therapeutics _gvol. 3 _gno. 5 _gp. 587-95
999			_c14850299 _d14850299